Accessibility Menu
Stemsation International logo

Stemsation International(OTC) STSN

Current Price$0.02
Market Cap$10.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-95%
5 Year-35%
1 Year+115%
1 Month+315%
Stemsation International last closing stock price
MetricPriceDate
Last closeUSD 0.022026-07-24
Stemsation International stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+37.1%USD 0.012026-07-17
1 month+314.63%USD 0.002026-06-23
3 month+431.25%USD 0.002026-04-23
Year to date+466.67%USD 0.002025-12-29
1 year+115.19%USD 0.012025-07-24
3 year+54.55%USD 0.012023-07-25
5 year-35.11%USD 0.032021-07-21
Since inception-95.14%USD 0.352008-01-31

Stemsation International Financials at a Glance

Market Cap

$10.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$429.73K

EPS (TTM)

-$0.00

P/E Ratio

-24.29

Dividend

$0.00

Beta (Volatility)

-0.28 (Low)

Price

$0.02

Volume

110,000

Open

$0.02

Previous Close

$0.02

Daily Range

$0.01 - $0.02

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

N/A

STSN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stemsation International

Stemsation International, Inc. is a healthcare company based in Boca Raton, Florida, focused on developing and distributing natural wellness products. The company specializes in enhancing the human body's stem cell and endocannabinoid systems through innovative nutritional supplements.

Products and Services
  • StemRCM, a nutritional supplement for stem cell enhancement
  • Direct-to-consumer sales through independent health advocates
  • Focus on natural wellness and holistic health solutions
Growth Outlook
  • Market demand for natural wellness products is increasing
  • Expansion of product offerings planned for the upcoming year
  • Potential partnerships with health and wellness influencers
Financial Highlights
  • Trailing twelve months (TTM) revenue of $0, indicating a focus on product development
  • Recent quarterly net income of -$151,110, reflecting ongoing investment in growth
  • Current ratio of 0.19, highlighting liquidity challenges
Stemsation International, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, emphasizing the development of products that support the body's natural healing processes. The company’s flagship product, StemRCM, aims to enhance the body's stem cell function, which is increasingly relevant in today's health-conscious market. The growth outlook for Stemsation is promising, driven by a rising consumer interest in natural wellness solutions. The company plans to expand its product line and explore partnerships that could enhance its market presence. Financially, the company is currently in a phase of investment, as indicated by the recent quarterly net income loss. The absence of revenue in the trailing twelve months suggests a strategic focus on product development rather than immediate profitability. The current ratio indicates liquidity challenges, which may require careful management as the company seeks to grow. Overall, Stemsation International, Inc. presents an intriguing opportunity for investors interested in the natural wellness sector, particularly as the market for such products continues to expand.
AI Generated • Jul 9, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Benjamin Alexander Silber

Website

stsninc.com

Headquarters

Plantation, FL 33434, US

STSN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-3.87%

Return on Capital

-3.13%

Return on Assets

-3.31%

Earnings Yield

-4.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

620.45M

Volume

110.00K

Avg. Volume

269.20K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$367.80K

EBITDA

-$367.80K

Operating Cash Flow

-$386.24K

Capital Expenditure

-$4.00

Free Cash Flow

-$386.24K

Cash & ST Invst.

$2.54K

Total Debt

$1.54M

Stemsation International Performance Analysis

Stemsation International annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Stemsation International sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Stemsation International annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00-62.9%
20232023-12-31USD -0.00-82.6%
20242024-12-31USD -0.00675.0%
20252025-12-31USD -0.00-74.2%
Stemsation International sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30200.0%
Q32025-09-30200.0%
Q42025-12-31-33.3%
Q12026-03-31-50.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$10.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.64M

N/A

Employees

4

N/A

Net Income

-$42.10K

+45.1%

EBITDA

-$31.95K

+42.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$2.54K

+98.3%

Total Debt

$1.54M

+39.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.54M

+39.4%

Return on Assets

-3.31%

N/A

Return on Invested Capital

-3.36%

N/A

Free Cash Flow

-$33.86K

-772.7%

Operating Cash Flow

-$33.86K

-772.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ERBBAmerican Green, Inc.
$0.00+50.00%
MGWFFMaple Leaf Green World Inc.
$0.02+0.00%
SKYISky Century Investment, Inc.
$0.25-5.66%
CSTFCuraScientific Corp
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About STSN

What is the current price of Stemsation International?

Stemsation International is trading at $0.02 per share.

What is the 52-week range for Stemsation International?

Over the past 52 weeks, Stemsation International has traded between $0.00 and $0.02.

How much debt does Stemsation International have?

As of the most recent reporting period, Stemsation International reported total debt of $1.54M.

How much cash does Stemsation International have on hand?

Stemsation International reported $2.54K in cash and cash equivalents in its most recent financial results.

What is Stemsation International’s dividend yield?

Stemsation International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services